|
Volumn 86, Issue 1, 2008, Pages 115-116
|
Intravitreal bevacizumab (Avastin®) for radiation retinopathy neovascularization [3]
c
NONE
(Spain)
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BEVACIZUMAB;
CISPLATIN;
NAVELBINE;
ANGIOGENESIS INHIBITOR;
MONOCLONAL ANTIBODY;
ADENOID CYSTIC CARCINOMA;
ADULT;
CASE REPORT;
DISEASE SEVERITY;
DRUG EFFICACY;
FOLLOW UP;
HUMAN;
LASER COAGULATION;
LETTER;
MALE;
OPHTHALMOSCOPY;
OUTCOME ASSESSMENT;
PRIORITY JOURNAL;
RADIATION DOSE;
RADIATION HAZARD;
RADIATION INJURY;
RETINA FLUORESCEIN ANGIOGRAPHY;
RETINA ISCHEMIA;
RETINA NEOVASCULARIZATION;
SLIT LAMP;
SUBCAPSULAR CATARACT;
VISUAL ACUITY;
VITREOUS HEMORRHAGE;
INJECTION;
MAXILLA SINUS CANCER;
VITREOUS BODY;
ADULT;
ANGIOGENESIS INHIBITORS;
ANTIBODIES, MONOCLONAL;
CARCINOMA, ADENOID CYSTIC;
HUMANS;
INJECTIONS;
MALE;
MAXILLARY SINUS NEOPLASMS;
RADIATION INJURIES;
RETINAL NEOVASCULARIZATION;
VITREOUS BODY;
|
EID: 39349109862
PISSN: 1755375X
EISSN: 16000420
Source Type: Journal
DOI: 10.1111/j.1600-0420.2007.00977.x Document Type: Letter |
Times cited : (18)
|
References (5)
|